Same Indication

Montelukast vs Tirzepatide

## Montelukast vs Tirzepatide: Overview

This comparison examines the pharmacological differences between **Montelukast** and **Tirzepatide**.

## Mechanism of Action

**Montelukast**: Selective leukotriene D4 receptor antagonist.

**Tirzepatide**: Dual GIP and GLP-1 receptor agonist.

## Pharmacokinetics

**Half-life**: Montelukast — 2.7-5.5 hours; Tirzepatide — 5 days.

## Chemical Properties

**Molecular Formula**: Montelukast — C35H36ClNO3S; Tirzepatide — N/A.

**Molecular Weight**: Montelukast — 586.1800 g/mol; Tirzepatide — N/A.

**Type**: Montelukast — Small molecule; Tirzepatide — Protein.